171 related articles for article (PubMed ID: 15475567)
1. Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas.
Pacifico F; Mauro C; Barone C; Crescenzi E; Mellone S; Monaco M; Chiappetta G; Terrazzano G; Liguoro D; Vito P; Consiglio E; Formisano S; Leonardi A
J Biol Chem; 2004 Dec; 279(52):54610-9. PubMed ID: 15475567
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
[TBL] [Abstract][Full Text] [Related]
3. R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.
Festa M; Petrella A; Alfano S; Parente L
Int J Cancer; 2009 Jun; 124(11):2728-36. PubMed ID: 19230027
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis.
Fujioka S; Sclabas GM; Schmidt C; Niu J; Frederick WA; Dong QG; Abbruzzese JL; Evans DB; Baker C; Chiao PJ
Oncogene; 2003 Mar; 22(9):1365-70. PubMed ID: 12618762
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nuclear factor-kappaB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells.
Starenki D; Namba H; Saenko V; Ohtsuru A; Yamashita S
J Clin Endocrinol Metab; 2004 Jan; 89(1):410-8. PubMed ID: 14715879
[TBL] [Abstract][Full Text] [Related]
6. NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B.
Javelaud D; Besançon F
Oncogene; 2001 Jul; 20(32):4365-72. PubMed ID: 11466617
[TBL] [Abstract][Full Text] [Related]
7. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-kB in thyroid carcinogenesis and progression: a novel therapeutic target for advanced thyroid cancer.
Namba H; Saenko V; Yamashita S
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):843-51. PubMed ID: 17891249
[TBL] [Abstract][Full Text] [Related]
10. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.
Burrows N; Resch J; Cowen RL; von Wasielewski R; Hoang-Vu C; West CM; Williams KJ; Brabant G
Endocr Relat Cancer; 2010 Mar; 17(1):61-72. PubMed ID: 19808899
[TBL] [Abstract][Full Text] [Related]
11. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells.
Iannetti A; Pacifico F; Acquaviva R; Lavorgna A; Crescenzi E; Vascotto C; Tell G; Salzano AM; Scaloni A; Vuttariello E; Chiappetta G; Formisano S; Leonardi A
Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14058-63. PubMed ID: 18768801
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
Shishodia S; Koul D; Aggarwal BB
J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936
[TBL] [Abstract][Full Text] [Related]
13. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
[TBL] [Abstract][Full Text] [Related]
14. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 2000 May; 164(10):5156-66. PubMed ID: 10799874
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.
Huang Y; Johnson KR; Norris JS; Fan W
Cancer Res; 2000 Aug; 60(16):4426-32. PubMed ID: 10969788
[TBL] [Abstract][Full Text] [Related]
16. BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation.
Palona I; Namba H; Mitsutake N; Starenki D; Podtcheko A; Sedliarou I; Ohtsuru A; Saenko V; Nagayama Y; Umezawa K; Yamashita S
Endocrinology; 2006 Dec; 147(12):5699-707. PubMed ID: 16959844
[TBL] [Abstract][Full Text] [Related]
17. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.
Hwang JH; Hwang JH; Chung HK; Kim DW; Hwang ES; Suh JM; Kim H; You KH; Kwon OY; Ro HK; Jo DY; Shong M
J Clin Endocrinol Metab; 2003 Jan; 88(1):408-16. PubMed ID: 12519884
[TBL] [Abstract][Full Text] [Related]
18. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
19. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Starenki DV; Namba H; Saenko VA; Ohtsuru A; Maeda S; Umezawa K; Yamashita S
Clin Cancer Res; 2004 Oct; 10(20):6821-9. PubMed ID: 15501958
[TBL] [Abstract][Full Text] [Related]
20. Characterization of signaling pathways leading to Fas expression induced by TNF-alpha: pivotal role of NF-kappaB.
Starace D; Riccioli A; D'Alessio A; Giampietri C; Petrungaro S; Galli R; Filippini A; Ziparo E; De Cesaris P
FASEB J; 2005 Mar; 19(3):473-5. PubMed ID: 15601669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
